Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Papa Medical Inc.

CIK 2024283Updated Nov 16, 2026

Securities
Historical securities (1)PAPA · OTC · equity · closed Jan 4, 2022

PAPA price & chart

Provider market data
Historical security

This listing closed Jan 4, 2022. Live provider charts are shown only for current listings.

About the company

We are a pioneering provider of end-to-end innovative Hemp dosing solutions in the US that possesses the medical atomization and nebulizing background and sells nebulizers. We engage in the key activities in the Hemp cannabinoid E-vapors industry, including the research and development, formulation design, e-liquid production, e-liquid filling and e-liquid co-packing services. We believe our full-cycle operations and leading market position will position us to further capitalize on the growth potential of the Hemp cannabinoid E-vapors market in the United States.

S-1/A · 2026-03-20 · 0001213900-26-032037

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Recent filings

  1. S-1/A filing

    S-1/A · 2026-03-20 · 0001213900-26-032037

  2. RW filing

    RW · 2025-12-15 · 0001213900-25-121450

  3. RW filing

    RW · 2025-12-15 · 0001213900-25-121449

  4. S-1 filing

    S-1 · 2025-11-26 · 0001213900-25-115290

  5. 10-Q filing

    10-Q · 2025-11-14 · 0001213900-25-110264

Show 5 more recent filings
  1. POS AM filing

    POS AM · 2025-09-29 · 0001213900-25-092607

  2. 10-Q filing

    10-Q · 2025-09-25 · 0001213900-25-091364

  3. EFFECT filing

    EFFECT · 2025-08-12 · 9999999995-25-002571

  4. CORRESP filing

    CORRESP · 2025-08-08 · 0001213900-25-073861

  5. CORRESP filing

    CORRESP · 2025-08-08 · 0001213900-25-073859

Offerings

Registration 333-291803

S-1/A · 2026-03-20 · 0001213900-26-032037

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-283405

S-1/A · 2025-08-07 · 0001213900-25-072819

Terms from the governing filing for this registration; not a claim that the offering is open today.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.